Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

By Sam | November 29, 2017

Sanofi’s setback could open the door for rival drugmaker Takeda.
Source: BioSpace

Posted in BioPharma